Response of preclinical medulloblastoma models to combination therapy with 13-cis retinoic acid and suberoylanilide hydroxamic acid (SAHA). (Q40039338)
Jump to navigation
Jump to search
scientific article published on 5 December 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Response of preclinical medulloblastoma models to combination therapy with 13-cis retinoic acid and suberoylanilide hydroxamic acid (SAHA). |
scientific article published on 5 December 2007 |
Statements
1 reference
Response of preclinical medulloblastoma models to combination therapy with 13-cis retinoic acid and suberoylanilide hydroxamic acid (SAHA). (English)
1 reference
Susan E Spiller
1 reference
Sally H Ditzler
1 reference
Barbara J Pullar
1 reference
James M Olson
1 reference
5 December 2007
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference